tiprankstipranks
Trending News
More News >
CVS Health Corp (CH:CVS)
:CVS
Switzerland Market
Advertisement

CVS Health (CVS) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

CVS Analyst Ratings

Strong Buy
19Ratings
Strong Buy
18 Buy
1 Hold
0 Sell
Based on 19 analysts giving stock ratings to
CVS
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CVS Stock 12 Month Forecast

Average Price Target

$68.89
Based on 19 Wall Street analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is $68.89 with a high forecast of $81.51 and a low forecast of $59.35. The average price target represents a change from the last price of .
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
Highest Price Target$81.51Average Price Target$68.89Lowest Price Target$59.35
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on CH:CVS
Leerink Partners
Leerink Partners
CHF68.05CHF75.18
Buy
Reiterated
10/17/25
Leerink Partners Sticks to Their Buy Rating for CVS Health (CVS)
Bernstein Analyst forecast on CH:CVS
Bernstein
Bernstein
CHF60.93
Hold
Reiterated
10/16/25
Bernstein Keeps Their Hold Rating on CVS Health (CVS)
RBC Capital Analyst forecast on CH:CVS
RBC Capital
RBC Capital
Buy
Reiterated
10/15/25
Analysts' Top Healthcare Picks: CVS Health (CVS), Rhythm Pharmaceuticals (RYTM)
Morgan Stanley Analyst forecast on CH:CVS
Morgan Stanley
Morgan Stanley
CHF64.89CHF70.43
Buy
Reiterated
10/14/25
CVS Health price target raised to $89 from $82 at Morgan StanleyCVS Health price target raised to $89 from $82 at Morgan Stanley
Truist Financial Analyst forecast on CH:CVS
Truist Financial
Truist Financial
CHF66.47CHF72.8
Buy
Reiterated
10/14/25
CVS Health price target raised to $92 from $84 at TruistCVS Health price target raised to $92 from $84 at Truist
Goldman Sachs Analyst forecast on CH:CVS
Goldman Sachs
Goldman Sachs
CHF72.01
Buy
Initiated
10/14/25
CVS Health (CVS) Gets a Buy from Goldman Sachs
Cantor Fitzgerald Analyst forecast on CH:CVS
Cantor Fitzgerald
Cantor Fitzgerald
CHF61.72
Buy
Reiterated
10/10/25
Cantor Fitzgerald Reaffirms Their Buy Rating on CVS Health (CVS)
Bank of America Securities Analyst forecast on CH:CVS
Bank of America Securities
Bank of America Securities
CHF70.43
Buy
Reiterated
10/10/25
Analysts Offer Insights on Healthcare Companies: CVS Health (NYSE: CVS), Stoke Therapeutics (NASDAQ: STOK) and Humana (NYSE: HUM)
UBS
CHF62.51
Buy
Reiterated
10/10/25
Positive Outlook for CVS Health Amid Minor Challenges: Buy Rating Affirmed
TD Cowen
CHF75.18CHF78.34
Buy
Reiterated
10/09/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: CVS Health (NYSE: CVS) and BioMarin Pharmaceutical (NASDAQ: BMRN)
Mizuho Securities Analyst forecast on CH:CVS
Mizuho Securities
Mizuho Securities
CHF61.72CHF69.64
Buy
Reiterated
10/08/25
CVS Health price target raised to $88 from $76 at MizuhoCVS Health price target raised to $88 from $76 at Mizuho
Evercore ISI
CHF67.26
Buy
Reiterated
10/08/25
Evercore ISI Sticks to Its Buy Rating for CVS Health (CVS)
Wells Fargo Analyst forecast on CH:CVS
Wells Fargo
Wells Fargo
CHF66.47CHF81.51
Buy
Reiterated
10/07/25
CVS Health price target raised to $103 from $84 at Wells FargoCVS Health price target raised to $103 from $84 at Wells Fargo
Wolfe Research Analyst forecast on CH:CVS
Wolfe Research
Wolfe Research
CHF63.31CHF67.26
Buy
Reiterated
09/22/25
Wolfe Research Reaffirms Their Buy Rating on CVS Health (CVS)
Raymond James Analyst forecast on CH:CVS
Unknown Analyst
Raymond James
Not Ranked
Raymond James
CHF55.6CHF59.35
Buy
Reiterated
09/09/25
CVS Health (CVS) Receives a Buy from Raymond James
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on CH:CVS
Leerink Partners
Leerink Partners
CHF68.05CHF75.18
Buy
Reiterated
10/17/25
Leerink Partners Sticks to Their Buy Rating for CVS Health (CVS)
Bernstein Analyst forecast on CH:CVS
Bernstein
Bernstein
CHF60.93
Hold
Reiterated
10/16/25
Bernstein Keeps Their Hold Rating on CVS Health (CVS)
RBC Capital Analyst forecast on CH:CVS
RBC Capital
RBC Capital
Buy
Reiterated
10/15/25
Analysts' Top Healthcare Picks: CVS Health (CVS), Rhythm Pharmaceuticals (RYTM)
Morgan Stanley Analyst forecast on CH:CVS
Morgan Stanley
Morgan Stanley
CHF64.89CHF70.43
Buy
Reiterated
10/14/25
CVS Health price target raised to $89 from $82 at Morgan StanleyCVS Health price target raised to $89 from $82 at Morgan Stanley
Truist Financial Analyst forecast on CH:CVS
Truist Financial
Truist Financial
CHF66.47CHF72.8
Buy
Reiterated
10/14/25
CVS Health price target raised to $92 from $84 at TruistCVS Health price target raised to $92 from $84 at Truist
Goldman Sachs Analyst forecast on CH:CVS
Goldman Sachs
Goldman Sachs
CHF72.01
Buy
Initiated
10/14/25
CVS Health (CVS) Gets a Buy from Goldman Sachs
Cantor Fitzgerald Analyst forecast on CH:CVS
Cantor Fitzgerald
Cantor Fitzgerald
CHF61.72
Buy
Reiterated
10/10/25
Cantor Fitzgerald Reaffirms Their Buy Rating on CVS Health (CVS)
Bank of America Securities Analyst forecast on CH:CVS
Bank of America Securities
Bank of America Securities
CHF70.43
Buy
Reiterated
10/10/25
Analysts Offer Insights on Healthcare Companies: CVS Health (NYSE: CVS), Stoke Therapeutics (NASDAQ: STOK) and Humana (NYSE: HUM)
UBS
CHF62.51
Buy
Reiterated
10/10/25
Positive Outlook for CVS Health Amid Minor Challenges: Buy Rating Affirmed
TD Cowen
CHF75.18CHF78.34
Buy
Reiterated
10/09/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: CVS Health (NYSE: CVS) and BioMarin Pharmaceutical (NASDAQ: BMRN)
Mizuho Securities Analyst forecast on CH:CVS
Mizuho Securities
Mizuho Securities
CHF61.72CHF69.64
Buy
Reiterated
10/08/25
CVS Health price target raised to $88 from $76 at MizuhoCVS Health price target raised to $88 from $76 at Mizuho
Evercore ISI
CHF67.26
Buy
Reiterated
10/08/25
Evercore ISI Sticks to Its Buy Rating for CVS Health (CVS)
Wells Fargo Analyst forecast on CH:CVS
Wells Fargo
Wells Fargo
CHF66.47CHF81.51
Buy
Reiterated
10/07/25
CVS Health price target raised to $103 from $84 at Wells FargoCVS Health price target raised to $103 from $84 at Wells Fargo
Wolfe Research Analyst forecast on CH:CVS
Wolfe Research
Wolfe Research
CHF63.31CHF67.26
Buy
Reiterated
09/22/25
Wolfe Research Reaffirms Their Buy Rating on CVS Health (CVS)
Raymond James Analyst forecast on CH:CVS
Unknown Analyst
Raymond James
Not Ranked
Raymond James
CHF55.6CHF59.35
Buy
Reiterated
09/09/25
CVS Health (CVS) Receives a Buy from Raymond James
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CVS Health

1 Month
xxx
Success Rate
11/18 ratings generated profit
61%
Average Return
+0.31%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 61.11% of your transactions generating a profit, with an average return of +0.31% per trade.
3 Months
xxx
Success Rate
13/21 ratings generated profit
62%
Average Return
+6.31%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.90% of your transactions generating a profit, with an average return of +6.31% per trade.
1 Year
Success Rate
15/21 ratings generated profit
71%
Average Return
+17.19%
reiterated a buy rating 11 days ago
Copying Elizabeth Anderson CFA's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +17.19% per trade.
2 Years
xxx
Success Rate
20/20 ratings generated profit
100%
Average Return
+28.34%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +28.34% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CVS Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
0
0
3
3
3
Buy
37
35
33
36
38
Hold
5
7
4
6
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
42
42
40
45
45
In the current month, CVS has received 41 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. CVS average Analyst price target in the past 3 months is 68.89.
Each month's total comprises the sum of three months' worth of ratings.

CVS Financial Forecast

CVS Earnings Forecast

Next quarter’s earnings estimate for CVS is $1.09 with a range of $0.98 to $1.22. The previous quarter’s EPS was $1.44. CVS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year CVS has Preformed in-line its overall industry.
Next quarter’s earnings estimate for CVS is $1.09 with a range of $0.98 to $1.22. The previous quarter’s EPS was $1.44. CVS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year CVS has Preformed in-line its overall industry.

CVS Sales Forecast

Next quarter’s sales forecast for CVS is $78.44B with a range of $77.14B to $81.70B. The previous quarter’s sales results were $78.49B. CVS beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year CVS has Preformed in-line its overall industry.
Next quarter’s sales forecast for CVS is $78.44B with a range of $77.14B to $81.70B. The previous quarter’s sales results were $78.49B. CVS beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year CVS has Preformed in-line its overall industry.

CVS Stock Forecast FAQ

What is CH:CVS’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Health Corp’s 12-month average price target is 68.89.
    What is CH:CVS’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:CVS, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is CVS Health Corp a Buy, Sell or Hold?
        CVS Health Corp has a consensus rating of Strong Buy, which is based on 18 buy ratings, 1 hold ratings and 0 sell ratings.
          What is CVS Health Corp’s share price target?
          The average share price target for CVS Health Corp is 68.89. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $81.51 ,and the lowest forecast is $59.35. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about CVS Health Corp?
            CVS Health Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
              How can I buy shares of CVS Health Corp?
              To buy shares of CH:CVS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis